Farallon Capital Management 13F holdings, Q3 2017
Holdings as of September 30, 2017 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 83 US equity positions worth $9.6bn in its Q3 2017 13F filing. The largest position was NXPI at 9.1% of the reported book, followed by TIME WARNER INC and ALTABA INC. Against the Q2 2017 filing, it opened 11 new positions, added to 19 and reduced 16 among the top 50 holdings.
What did Farallon Capital Management own in Q3 2017? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2017 |
|---|---|---|---|---|---|---|---|
| 1 | NXPI NXP SEMICONDUCTORS N V | Technology | 9.1% | $873.6m | 7,725,000 | 20% | added |
| 2 | TIME WARNER INC | 9.0% | $862.8m | 8,422,000 | 21% | added | |
| 3 | ALTABA INC | 8.4% | $803.0m | 12,122,457 | -2% | reduced | |
| 4 | BARD C R INC | 5.3% | $508.0m | 1,585,000 | 8% | added | |
| 5 | GOOG ALPHABET INC | Communication Services | 3.9% | $374.4m | 390,324 | 27% | added |
| 6 | DELL DELL TECHNOLOGIES INC | Technology | 3.6% | $348.5m | 4,513,440 | 17% | added |
| 7 | WAB WABTEC CORP | Industrials | 3.5% | $336.4m | 4,440,356 | 38% | added |
| 8 | PLAYA HOTELS & RESORTS NV | 3.3% | $319.2m | 30,606,930 | 0% | held | |
| 9 | META FACEBOOK INC | Communication Services | 3.3% | $316.8m | 1,853,979 | -20% | reduced |
| 10 | QUINTILES IMS HOLDINGS INC | 3.1% | $295.5m | 3,108,053 | -20% | reduced | |
| 11 | V VISA INC | Financial Services | 2.6% | $248.8m | 2,363,668 | -16% | reduced |
| 12 | CITRIX SYS INC | 2.3% | $223.4m | 2,908,562 | 81% | added | |
| 13 | HD SUPPLY HLDGS INC | 2.0% | $196.0m | 5,434,168 | -12% | reduced | |
| 14 | MSFT MICROSOFT CORP | Technology | 2.0% | $191.9m | 2,576,812 | 4% | added |
| 15 | KITE PHARMA INC | 1.8% | $175.2m | 974,435 | – | new | |
| 16 | RADIUS HEALTH INC | 1.6% | $151.7m | 3,936,300 | 7% | added | |
| 17 | BIIB BIOGEN INC | Healthcare | 1.6% | $148.7m | 475,000 | 124% | added |
| 18 | FIS FIDELITY NATL INFORMATION SV | Technology | 1.5% | $147.1m | 1,574,586 | 5% | added |
| 19 | IHS MARKIT LTD | 1.5% | $139.8m | 3,170,699 | 14% | added | |
| 20 | ALERE INC | 1.4% | $137.7m | 2,700,000 | -38% | reduced | |
| 21 | EFX EQUIFAX INC | Industrials | 1.4% | $136.7m | 1,290,000 | – | new |
| 22 | VRSK VERISK ANALYTICS INC | Industrials | 1.4% | $136.1m | 1,635,807 | 239% | added |
| 23 | STZ CONSTELLATION BRANDS INC | Consumer Defensive | 1.4% | $130.6m | 654,869 | -7% | reduced |
| 24 | VEON VEON LTD | 1.3% | $123.0m | 29,433,518 | 44% | added | |
| 25 | TRU TRANSUNION | Financial Services | 1.1% | $109.7m | 2,322,158 | – | new |
| 26 | HERBALIFE LTD | 1.1% | $108.3m | 108,177,000 | 0% | held | |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.1% | $107.7m | 3,180,000 | 453% | added |
| 28 | BUD ANHEUSER BUSCH INBEV SA/NV | Consumer Defensive | 1.1% | $107.4m | 900,000 | – | new |
| 29 | LIBERTY GLOBAL PLC | 1.1% | $101.5m | 2,992,935 | -29% | reduced | |
| 30 | LIBERTY GLOBAL PLC | 1.1% | $101.0m | 3,089,773 | -29% | reduced | |
| 31 | HUN HUNTSMAN CORP | Basic Materials | 1.0% | $96.0m | 3,500,000 | -35% | reduced |
| 32 | CALPINE CORP | 1.0% | $95.3m | 6,460,000 | – | new | |
| 33 | BMY BRISTOL MYERS SQUIBB CO | Healthcare | 0.9% | $86.4m | 1,355,000 | – | new |
| 34 | HLF HERBALIFE LTD | Consumer Defensive | 0.9% | $85.5m | 1,259,835 | -40% | reduced |
| 35 | SOLARCITY CORP | 0.8% | $78.1m | 82,332,000 | -42% | reduced | |
| 36 | AM6 AMICUS THERAPEUTICS INC | 0.8% | $76.6m | 5,081,055 | 69% | added | |
| 37 | GILD GILEAD SCIENCES INC | Healthcare | 0.8% | $76.6m | 945,000 | – | new |
| 38 | AKORN INC | 0.8% | $75.7m | 2,280,000 | – | new | |
| 39 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 0.7% | $69.5m | 191,255 | -43% | reduced |
| 40 | GENERAL COMMUNICATION INC | 0.7% | $67.1m | 1,643,800 | 157% | added | |
| 41 | CMCSA COMCAST CORP NEW | Communication Services | 0.7% | $67.0m | 1,741,621 | -48% | reduced |
| 42 | BROCADE COMMUNICATIONS SYS I | 0.6% | $61.3m | 5,130,000 | – | new | |
| 43 | FIBROGEN INC | 0.6% | $59.2m | 1,100,000 | 3% | added | |
| 44 | ABBV ABBVIE INC | Healthcare | 0.5% | $52.0m | 585,000 | -30% | reduced |
| 45 | ELV ANTHEM INC | Healthcare | 0.4% | $39.9m | 210,000 | 0% | held |
| 46 | SUTHERLAND ASSET MGMT CORP M | 0.4% | $36.5m | 2,324,236 | 0% | held | |
| 47 | XLRN ACCELERON PHARMA INC | 0.4% | $35.9m | 963,000 | – | new | |
| 48 | GRFS GRIFOLS S A | Healthcare | 0.3% | $31.3m | 1,429,773 | 32% | added |
| 49 | ENSCO PLC | 0.3% | $29.4m | 4,920,000 | – | new | |
| 50 | EXEL EXELIXIS INC | Healthcare | 0.3% | $28.8m | 1,190,000 | -21% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.